ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $22.00 price target on the stock. This represents a 19.6% upside from the current price of $18.39. |
Alkermes (NASDAQ:ALKS) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $40.00 price target on the stock. This represents a 27.4% upside from the current price of $31.40. |
Avadel Pharmaceuticals (NASDAQ:AVDL) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $12.00 price target on the stock. This represents a 34.4% upside from the current price of $8.93. |
Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $176.00 price target on the stock. This represents a 32.0% upside from the current price of $133.29. |
AZZ (NYSE:AZZ) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $108.00 price target on the stock. This represents a 10.7% upside from the current price of $97.57. |
Biohaven (NYSE:BHVN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $65.00 price target on the stock. This represents a 63.1% upside from the current price of $39.84. |
Biogen (NASDAQ:BIIB) is now covered by analysts at Sanford C. Bernstein. They set a “market perform” rating and a $160.00 price target on the stock. This represents a 13.8% upside from the current price of $140.66. |
Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at TD Cowen. They set a “buy” rating on the stock.The current price is $35.68. |
Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $31.00 price target on the stock. This represents a 45.9% upside from the current price of $21.25. |
Domo (NASDAQ:DOMO) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $11.00 price target on the stock. This represents a 22.6% upside from the current price of $8.97. |
ECARX (NASDAQ:ECX) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $3.20 price target on the stock. This represents a 61.5% upside from the current price of $1.98. |
Flex (NASDAQ:FLEX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $52.00 price target on the stock. This represents a 20.5% upside from the current price of $43.15. |
Gaia (NASDAQ:GAIA) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $10.00 price target on the stock. This represents a 89.8% upside from the current price of $5.27. |
Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $55.00 price target on the stock. This represents a 45.5% upside from the current price of $37.81. |
International Business Machines (NYSE:IBM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $320.00 price target on the stock. This represents a 26.9% upside from the current price of $252.17. |
Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $138.00 price target on the stock. This represents a 18.8% upside from the current price of $116.21. |
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $111.00 price target on the stock. This represents a 38.2% upside from the current price of $80.35. |
Silence Therapeutics (NASDAQ:SLN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “sell” rating and a $6.00 price target on the stock. This represents a 34.7% upside from the current price of $4.46. |
Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $136.00 price target on the stock. This represents a 23.1% upside from the current price of $110.52. |
Sunrise Realty Trust (NASDAQ:SUNS) is now covered by analysts at Keefe, Bruyette & Woods. They set an “outperform” rating and a $12.75 price target on the stock. This represents a 9.5% upside from the current price of $11.65. |
TTM Technologies (NASDAQ:TTMI) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $33.00 price target on the stock. This represents a 24.3% upside from the current price of $26.54. |
Waystar (NASDAQ:WAY) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $51.00 price target on the stock. This represents a 22.5% upside from the current price of $41.64. |
Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $67.00 price target on the stock. This represents a 72.1% upside from the current price of $38.94. |